Study links common drugs to a lower level of prostate-specific antigen

08/8/2010 | HealthDay News

Commonly used drugs such as painkillers and statins might cause errors in diagnostic tests for prostate cancer because they appear to reduce the level of prostate-specific antigen, researchers reported. "If future studies show that the difference in [prostate-specific antigen] has no bearing on the development of prostate cancer, then it may be necessary to lower the [prostate-specific antigen] threshold for recommending prostate needle biopsies in men who are taking [nonsteroidal anti-inflammatory drugs], statins and thiazide diuretics," the study's lead author said.

View Full Article in:

HealthDay News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Assistant General Counsel, Regulatory
Cardinal Health
Waukegan, IL
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Sr Manager, Business Conduct
Gilead Sciences
Foster City, CA
Chief Executive Officer
UCare Minnesota
Minneapolis, MN